Nitroxoline as an antimicrobial synergist reverses colistin resistance in multidrug-resistant Escherichia coli
Year: 2025
Type: article
Abstract: infections. In conclusion, NTX is identified as a promising colistin adjuvant for the treatment of colistin-resistant bacterial infections.
Source: iScience
Authors: Hao Wang, Jie He, Hao Li, Chengming Li, Muhammad Inam, Jianfeng Wang, Huifeng Dong, Dingkuo Liu, Fang Liu, Jingrui Chen, Yu Jia, Yunhang Gao, Lingcong Kong, Hongxia Ma
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,240
Award: G4691632882
OpenAlex ID: W4416119009
